WCN25-2440 CLINICAL PROFILE AND OUTCOME OF ANTIBODY-MEDIATED REJECTION FROM A TERTIARY CARE CENTRE IN NORTH EAST INDIA

Antibody mediated rejection (ABMR) also termed humoral rejection is one of the most important causes of allograft dysfunction. Active ABMR clinically occur within few months of transplantation and present with acute renal failure or oliguria that may be severe enough to require dialysis. Clinically chronic active ABMR patients present with chronic renal dysfunction with proteinuria. This study aim to analyse clinical profile and outcome of biopsy proven ABMR among renal allograft recipients (RAR).